NBR 08 Volunter Recall
Defining the mechanisms and control of human regulatory T cell function in autoimmunity.
Prof. Graham Lord
King’s College London

NBR 09 Volunteer Recall
Determining an important functional role for integrins in regulating immune responses in IBD
Prof. Mark Travis
University of Manchester

NBR 11 Access to samples/data
Progressing from genetics to function and clinical translation in Crohn’s disease & ulcerative colitis
Dr Miles Parkes
University of Cambridge

NBR 12 Volunteer Recall
GEM – Genetic, environmental, microbial project
Dr Miles Parkes
University of Cambridge

NBR 16 Volunteer Recall
The PREdiCCt (The PRognostic effect of Environmental factors in Crohn’s and Colitis) Study
Prof. Charlie Lees
University of Edinburgh

NBR 18 Volunteer Recall
Genetics and metagenome studies in orofacial granulomatosis
Dr Natalie Prescott
King’s College London

NBR 20 Access to samples/data
PANTS – Genetics of immunogenicity to anti-TNF drugs
Dr Tariq Ahmed
University of Exeter

NBR 21 Volunteer Recall
Mechanism linking NOD2 with MHC class I antigen presentation
Prof. Alison Simmons
University of Oxford

NBR 22 Access to samples/data
CMV infection in inflammatory bowel disease
Prof. Holm Uhlig
University of Oxford

NBR 28 Volunteer Recall
Crohn’s Anal Fistula Quality of Life Scale
Dr Ailsa Hart
London NW Healthcare NHS Trust

NBR 34 Volunteer Recall
IBD-Boost Survey: fatigue pain and urgency in IBD
Prof. Christine Norton
King’s College London

NBR 38 Access to samples/data
Understanding contributions of T cell determining factors in the pathogenesis of IBD
Prof Adrian Hayday
King’s College London

NBR 40 Volunteer Recall
IBD Risk Alleles – Effect of genetic variants associated with risk for inflammatory disease on immune cell phenotype and function.
Dr Carl Anderson
Wellcome Sanger Institute

NBR 42 Volunteer Recall
Determining the role of HLA variation in Inflammatory Bowel Disease
Prof Jack Satsangi
University of Oxford

NBR 47 Volunteer Recall
MODULATE (Management of diarrhoea in ulcerative colitis)
Prof. Alexander Ford
Leeds Institute of Medical Research (LIMR), St James’ University Hospital

NBR 48 Volunteer Recall
A longitudinal study of childlessness in women with IBD using the UK IBD BioResource
Dr Christian Selinger
Leeds Teaching Hospitals, St James University Hospital

NBR 52 Volunteer Recall
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of BMS-986165 in Subjects with Moderate-to-Severe Crohn’s Disease (ClinicalTrials.gov Identifier: NCT03599622)
Dr Tim Raine
Cambridge University Hospitals NHS Foundation Trust, Addenbrooke’s Hospital

NBR 56 Volunteer Recall
Using Saliva to PredIcT Crohn’s disease
Prof Laurence Lovat
University College London

NBR 58 Volunteer Recall
Predicting the behaviour of Crohn’s disease using MRI and ultrasound
Dr Stuart Taylor
University College London

NBR 59 Volunteer Recall
Safety, tolerability, efficacy and dose-response of GSK2831781 in patients with active ulcerative colitis.
Prof Simon Travis
GlaxoSmithKline plc

NBR 62 Volunteer Recall
The effects of the microbiome on the B cell receptor repertoire in patients with Ulcerative Colitis.
Prof Ken Smith
University of Cambridge

NBR 63 Access to samples/data
Identification of biomarkers to predict response to Vedolizumab in Inflammatory Bowel Disease.
Prof Jack Satsangi
University of Oxford

NBR 77 Access to samples/data and volunteer recall
CLARITY- ImpaCt of bioLogic therApy on saRs-CoV-2 infection and immuniTY in inflammatory bowel disease. 
Dr Tariq Ahmed
University of Exeter

Last Updated on